Kactus Biosystems
PrivateLast Round
Series B
Oct 20, 2022
Est. Valuation
$21.3M
Total Funding Raised
$54.75M
Company Overview
Kactus Biosystems is a biotechnology company specializing in protein engineering and manufacturing. Founded in March 2018, the company provides high-quality recombinant proteins, GMP-grade enzymes, and custom contract research services to support drug discovery, immunotherapy, gene editing, and mRNA therapeutics. Kactus utilizes its proprietary Structure-Aided Multiplex Screening (SAMS™) technology platform to produce difficult-to-express proteins with high bioactivity and purity. The company serves a global biopharma clientele from its headquarters in Shanghai, China, and its US operations in Waltham, MA. It has successfully raised venture capital funding to support its growth and expansion.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kactus Biosystems Comps
Public and private peers based on sector, stage, and business model.
Kactus Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 20, 2022 | ||||
| Series A Extension | Jul 8, 2021 | ||||
| Series A | Sep 28, 2020 | ||||
| Pre Seed | Dec 20, 2018 | ||||
| Angel | Apr 26, 2018 |
Kactus Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series B |
| Lingang Blue Bay Capital | Series B |
| Sherpa Healthcare Partners | Series A Extension |
| Dehui Capital | Series A Extension, Pre Seed |
| Guofang Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Partnered with AstraGenomics to commercialize gene editing tools.
- Feb 10, 2026
Attending the Festival of Biologics (FOB) USA 2026.
Kactus Biosystems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kactus Biosystems's valuation, stock price, and market status.
